Caring Today for a Healthier Tomorrow and Forever Find A Doctor
Caring Today for a Healthier Tomorrow and Forever Find A Doctor
Jamia Nagar Okhla, New Delhi – 110025
Jamia Nagar Okhla, New Delhi – 110025
Blood cancer, medically known as hematologic cancer, affects the production and function of blood cells. It usually begins in the bone marrow, where blood is produced. This form of cancer interferes with the normal development of blood cells, leading to serious health complications. The three major types of blood cancers are leukemia, lymphoma, and multiple myeloma, each affecting different parts of the blood-forming system.
India has emerged as a global hub for advanced and affordable blood cancer treatment. With the availability of state-of-the-art infrastructure, internationally trained oncologists, and personalized treatment protocols, patients from across the world, including Africa, the Middle East, and Southeast Asia, are increasingly choosing India for their hematologic cancer care. The country’s leading cancer hospitals offer a full range of services, including diagnostics, chemotherapy, targeted therapy, immunotherapy, bone marrow transplant (BMT), and post-treatment rehabilitation, ensuring a holistic and patient-centric approach.
Indian hospitals offer comprehensive diagnosis and treatment for all forms of blood cancer, including:
Leukemia: Cancer of the bone marrow and blood. Types include:
Acute Lymphoblastic Leukemia (ALL)
Acute Myeloid Leukemia (AML)
Chronic Lymphocytic Leukemia (CLL)
Chronic Myeloid Leukemia (CML)
Lymphoma: Affects the lymphatic system, which helps fight infections. Types include:
Hodgkin’s Lymphoma
Non-Hodgkin’s Lymphoma
Multiple Myeloma: A cancer of plasma cells that weakens bones and the immune system.
Myelodysplastic Syndromes (MDS) and Myeloproliferative Neoplasms (MPNs): Rare disorders affecting the bone marrow and blood cell production.
Approximately 100,000 new blood cancer cases are diagnosed annually in India, with around 70,000 deaths in 2022.
Leukemia was the most common in 2022 with ~49,883 cases, followed by Non-Hodgkin Lymphoma (~39,736) and Hodgkin Lymphoma (~9,611)
Childhood Acute Lymphoblastic Leukemia (ALL) cases at Nagpur’s GMCH rose sharply—from 22 cases in 2021‑22 to 35 in 2024‑25—an 82% increase in just one year.
Acute Myeloid Leukemia (AML) incidence in Delhi is around 3,000 cases yearly, with rising rates in individuals aged 30‑40.
India is the third-highest country globally for blood cancer cases, behind China and the USA .
Global data shows India had over 34,000 leukemia cases in 2021, with more than 32,000 related deaths .
Accurate diagnosis is critical for effective treatment. Patients undergo several tests to identify the specific type and stage of blood cancer, including:
Complete Blood Count (CBC)
Bone Marrow Biopsy and Aspiration
Flow Cytometry
Immunophenotyping
Genetic and Molecular Testing (e.g., BCR-ABL)
Imaging Tests: PET-CT, MRI, and X-rays
Lumbar Puncture (in select leukemia cases)
These tests help oncologists determine the nature and extent of the disease, which is vital for designing the best treatment strategy.
India provides cutting-edge treatment options for all types of blood cancer, delivered by expert hemato-oncologists and supported by multidisciplinary teams.
Chemotherapy remains the cornerstone for most blood cancers. Drugs are administered orally or intravenously to kill rapidly dividing cancer cells. India uses standardized global protocols, including pediatric-specific regimens and high-dose chemotherapy for aggressive cancers.
Targeted therapy uses drugs that specifically attack cancer cells with minimal damage to normal cells. India offers access to advanced agents such as:
Imatinib (for CML)
Rituximab (for NHL)
Dasatinib, Nilotinib, and more
These therapies are tailored based on the genetic and molecular profile of the cancer.
Immunotherapy enhances the body’s immune system to recognize and destroy cancer cells. CAR T-cell therapy, a highly advanced form of immunotherapy, is available in leading cancer centers in India for select patients.
Effective in relapsed/refractory leukemia and lymphoma
Uses patient’s own T-cells engineered to fight cancer
BMT is a curative option for many patients, particularly those with leukemia, lymphoma, and multiple myeloma. Indian hospitals offer:
Autologous Transplant (self-donor)
Allogeneic Transplant (matched donor)
Haploidentical and Matched Unrelated Donor (MUD) transplants
These are performed in sterile HEPA-filtered units to minimize infection risks.
Used selectively, especially in lymphoma cases or when cancer spreads to the brain/spine. Advanced radiotherapy systems like IMRT, IGRT, and CyberKnife are available in many Indian centers.
Blood transfusions
Platelet infusions
Pain management
Growth factor injections
Nutritional support
Psychosocial counseling
You may be eligible for treatment in India if you:
Have a confirmed diagnosis of leukemia, lymphoma, or myeloma
Require second opinion or access to advanced treatment
Are fit for intensive therapy or bone marrow transplant
Have a matched donor (related/unrelated) for transplant
Seek affordable and high-quality cancer care abroad
Patients must share their medical history, diagnostic reports, and treatment history for evaluation. Indian hospitals usually respond with a treatment plan and cost estimate within 48 hours.
Patients can share their reports online. A medical team evaluates the case and advises on suitable treatment.
On arrival, patients undergo further tests to confirm diagnosis and plan therapy.
Treatment begins with chemotherapy, targeted therapy, or BMT depending on the diagnosis. Some treatments require hospitalization.
Regular monitoring through blood tests and scans helps assess the effectiveness and adjust treatment.
Rehabilitation and follow-ups include dietary plans, immunity-boosting measures, and psychological support.
Chemotherapy: Full cycle may last 3-6 months; each cycle lasts 2-3 weeks.
Bone Marrow Transplant: Hospitalization for 3-4 weeks; recovery continues for 3-6 months.
Radiotherapy: Usually administered over 2-6 weeks depending on the plan.
Patients typically return to normal activity within a few months, depending on overall health, type of cancer, and treatment received.
|
Treatment Type |
Estimated Cost (INR) |
Estimated Cost (USD) |
|
Chemotherapy (per cycle) |
₹60,000 – ₹1,50,000 |
$750 – $1,800 |
|
Targeted Therapy |
₹1,50,000 – ₹4,00,000 |
$1,800 – $5,000 |
|
Bone Marrow Transplant |
₹12,00,000 – ₹25,00,000 |
$14,000 – $30,000 |
|
CAR T-Cell Therapy |
₹30,00,000 – ₹50,00,000 |
$36,000 – $60,000 |
India offers 60-70% savings compared to the US or Europe, with similar clinical outcomes.
World-Class Hospitals: NABH- and JCI-accredited hospitals with international facilities.
Experienced Oncologists: Doctors trained in top global institutions.
Advanced Technology: Modern diagnostics, precision radiotherapy, robotic surgery, and transplant units.
Affordable Pricing: World-class care at a fraction of global costs.
Medical Tourism Services: Visa assistance, interpreter support, airport pick-up, and accommodation help.
Minimal Wait Time: Immediate appointments and fast-tracked treatment planning.
Holistic Care: Multidisciplinary teams offering nutrition, physiotherapy, mental wellness, and palliative support.
India has reported high success rates for various types of blood cancers:
Childhood ALL: Over 85% long-term remission rate with standard protocols.
Hodgkin’s Lymphoma: 85-90% cure rate with combined chemo-radiation.
Bone Marrow Transplant: 60-80% success depending on match and type.
Multiple Myeloma: 60-70% long-term disease control.
Results depend on early diagnosis, cancer type, genetic profile, and overall patient condition.
1. Can international patients access blood cancer treatment in India?
Yes. Indian hospitals welcome patients globally and offer comprehensive medical tourism support.
2. Is a bone marrow transplant always required?
Not always. Many blood cancers are treatable with chemotherapy or targeted therapies.
3. What is the recovery period after a transplant?
Initial recovery takes 3-6 months, followed by long-term follow-up.
4. Is Indian cancer care safe and reliable?
Yes. Hospitals follow global protocols and are equipped with advanced technologies.
5. Can I bring my donor to India for BMT?
Yes. Hospitals facilitate matched sibling or unrelated donor transplants.
6. How do I initiate treatment from abroad?
Send your medical records to a selected hospital; a team will respond with treatment options and cost.
7. Are follow-up services available after returning home?
Yes. Hospitals provide digital consultations and long-term monitoring support.
8. What are the long-term side effects of blood cancer treatment?
Long-term effects may include fatigue, infertility, heart or lung problems, secondary cancers, or cognitive changes. Regular follow-ups and supportive care can help manage and minimize these risks.
9. Can blood cancer be detected early through routine tests?
Some blood cancers may show up in routine blood tests (like CBC), but many require further evaluation such as bone marrow biopsy or imaging. There is no standard screening for early detection.
10. Are alternative or supportive therapies available alongside conventional treatment?
Yes, many hospitals offer integrative care including nutrition counseling, physiotherapy, psychological support, and yoga therapy to improve overall wellbeing during and after treatment.
11. How do I choose the right hospital or doctor in India for blood cancer treatment?
Look for hospitals with NABH or JCI accreditation, dedicated hematology/oncology departments, and specialists experienced in treating your specific type of blood cancer. International patient coordinators can assist with appointments and travel planning.